Literature DB >> 32099191

Raynaud phenomenon and digital ulcers in systemic sclerosis.

Michael Hughes1,2, Yannick Allanore3, Lorinda Chung4, John D Pauling5,6, Christopher P Denton7, Marco Matucci-Cerinic8.   

Abstract

Raynaud phenomenon is a symptom complex caused by impaired digital perfusion and can occur as a primary phenomenon or secondary to a wide range of underlying causes. Raynaud phenomenon occurs in virtually all patients with systemic sclerosis (SSc) and is often the earliest clinical manifestation to occur. Careful assessment is required in patients with Raynaud phenomenon to avoid missing secondary causes such as SSc. Digital ulcers are a painful and disabling visible manifestation of digital vascular injury in patients with SSc. Progress has been made in the classification and assessment of digital ulcers and in understanding ulcer pathogenesis, and there are a wide range of treatments available to both prevent and heal digital ulcers, some of which are also used in Raynaud phenomenon management. In this Review, the assessment of patients with Raynaud phenomenon is discussed, including 'red flags' that are suggestive of SSc. The pathogenesis, classification and assessment of SSc-associated digital ulcers are also covered, alongside an overview of management approaches for SSc-associated Raynaud phenomenon and digital ulcers. Finally, unmet needs are discussed and the concept of a unified vascular phenotype in which therapies that affect the vasculature to support disease modification strategies is introduced.

Entities:  

Mesh:

Year:  2020        PMID: 32099191     DOI: 10.1038/s41584-020-0386-4

Source DB:  PubMed          Journal:  Nat Rev Rheumatol        ISSN: 1759-4790            Impact factor:   20.543


  60 in total

1.  Incidence and predictors of cutaneous manifestations during the early course of systemic sclerosis: a 10-year longitudinal study from the EUSTAR database.

Authors:  Elina G Wirz; Veronika K Jaeger; Yannick Allanore; Gabriela Riemekasten; Eric Hachulla; Oliver Distler; Paolo Airò; Patricia E Carreira; Mohammed Tikly; Serena Vettori; Alexandra Balbir Gurman; Nemanja Damjanov; Ulf Müller-Ladner; Jörg Distler; Mangtao Li; Peter Häusermann; Ulrich A Walker
Journal:  Ann Rheum Dis       Date:  2015-07-31       Impact factor: 19.103

2.  Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.

Authors:  E C LeRoy; C Black; R Fleischmajer; S Jablonska; T Krieg; T A Medsger; N Rowell; F Wollheim
Journal:  J Rheumatol       Date:  1988-02       Impact factor: 4.666

3.  A prospective study of systemic sclerosis-related digital ulcers: prevalence, location, and functional impact.

Authors:  H Ennis; A Vail; E Wragg; A Taylor; T Moore; A Murray; L Muir; C E M Griffiths; A L Herrick
Journal:  Scand J Rheumatol       Date:  2013-07-04       Impact factor: 3.641

Review 4.  Systemic sclerosis.

Authors:  Christopher P Denton; Dinesh Khanna
Journal:  Lancet       Date:  2017-04-13       Impact factor: 79.321

5.  Natural history of ischemic digital ulcers in systemic sclerosis: single-center retrospective longitudinal study.

Authors:  Eric Hachulla; Pierre Clerson; David Launay; Marc Lambert; Sandrine Morell-Dubois; Viviane Queyrel; Pierre-Yves Hatron
Journal:  J Rheumatol       Date:  2007-11-01       Impact factor: 4.666

Review 6.  Digital ulcers in systemic sclerosis.

Authors:  Michael Hughes; Ariane L Herrick
Journal:  Rheumatology (Oxford)       Date:  2016-04-19       Impact factor: 7.580

7.  Digital Ulcers in Systemic Sclerosis - Frequency, Subtype Distribution and Clinical Outcome.

Authors:  Sevdalina Lambova; Anastas Batalov; Lyubomir Sapundzhiev; Ulf Müller-Ladner
Journal:  Curr Rheumatol Rev       Date:  2013

8.  Measuring disease activity and functional status in patients with scleroderma and Raynaud's phenomenon.

Authors:  Peter A Merkel; Karen Herlyn; Richard W Martin; Jennifer J Anderson; Maureen D Mayes; Patrice Bell; Joseph H Korn; Robert W Simms; Mary Ellen Csuka; Thomas A Medsger; Naomi F Rothfield; Michael H Ellman; David H Collier; Arthur Weinstein; Daniel E Furst; Sergio A Jiménez; Barbara White; James R Seibold; Fredrick M Wigley
Journal:  Arthritis Rheum       Date:  2002-09

9.  Clinical features of scleroderma patients with or without prior or current ischemic digital ulcers: post-hoc analysis of a nationwide multicenter cohort (ItinérAIR-Sclérodermie).

Authors:  Kiet Phong Tiev; Elisabeth Diot; Pierre Clerson; Frédérique Dupuis-Siméon; Eric Hachulla; Pierre-Yves Hatron; Joël Constans; Daniéla Cirstéa; Dominique Farge-Bancel; Patrick H Carpentier
Journal:  J Rheumatol       Date:  2009-06-01       Impact factor: 4.666

Review 10.  Digital ulcers: overt vascular disease in systemic sclerosis.

Authors:  V Steen; C P Denton; J E Pope; M Matucci-Cerinic
Journal:  Rheumatology (Oxford)       Date:  2009-06       Impact factor: 7.580

View more
  17 in total

1.  Large vessel disease as a potentially treatable cause of devastating critical digital ischaemia in systemic sclerosis.

Authors:  Ashraful Haque; Trevor Cleveland; Lewis Powell; Sarah Stephenson; Michael Hughes; Rachael Kilding
Journal:  Clin Rheumatol       Date:  2020-05-08       Impact factor: 2.980

2.  Altered Properties of Endothelial Cells and Mesenchymal Stem Cells Underlying the Development of Scleroderma-like Vasculopathy in KLF5+/- ;Fli-1+/- Mice.

Authors:  Kouki Nakamura; Takashi Taniguchi; Megumi Hirabayashi; Takashi Yamashita; Ryosuke Saigusa; Shunsuke Miura; Takehiro Takahashi; Tetsuo Toyama; Yohei Ichimura; Ayumi Yoshizaki; Maria Trojanowska; Katsuhito Fujiu; Ryozo Nagai; Shinichi Sato; Yoshihide Asano
Journal:  Arthritis Rheumatol       Date:  2020-10-30       Impact factor: 10.995

3.  Angiographic characteristics of vasculopathy in patients with idiopathic inflammatory myopathies and systemic sclerosis.

Authors:  Jina Yeo; Eun-Ah Park; Eun Bong Lee; Jin Kyun Park
Journal:  Sci Rep       Date:  2022-05-31       Impact factor: 4.996

Review 4.  Anti-phospholipid syndrome leading to digital ischaemia and rare organ complications in systemic sclerosis and related disorders.

Authors:  Saion Chatterjee; John D Pauling
Journal:  Clin Rheumatol       Date:  2020-09-21       Impact factor: 2.980

5.  Raynaud's phenomenon.

Authors:  Ashraful Haque; Michael Hughes
Journal:  Clin Med (Lond)       Date:  2020-11       Impact factor: 2.659

6.  The impact of skin calcinosis on digital ulcers in patients with SSc: clinical and prognostic stratification using the "wound bed score".

Authors:  Simone Barsotti; Valentina Venturini; Marco Di Battista; Agata Janowska; Valentina Dini; Alessandra Della Rossa; Marta Mosca
Journal:  Int Wound J       Date:  2020-09-14       Impact factor: 3.315

Review 7.  Reproductive Issues and Pregnancy Implications in Systemic Sclerosis.

Authors:  Maria-Grazia Lazzaroni; Francesca Crisafulli; Liala Moschetti; Paolo Semeraro; Ana-Rita Cunha; Agna Neto; Andrea Lojacono; Francesca Ramazzotto; Cristina Zanardini; Sonia Zatti; Paolo Airò; Angela Tincani; Franco Franceschini; Laura Andreoli
Journal:  Clin Rev Allergy Immunol       Date:  2022-01-18       Impact factor: 8.667

Review 8.  New promising drugs for the treatment of systemic sclerosis: pathogenic considerations, enhanced classifications, and personalized medicine.

Authors:  Alain Lescoat; John Varga; Marco Matucci-Cerinic; Dinesh Khanna
Journal:  Expert Opin Investig Drugs       Date:  2021-05-13       Impact factor: 6.498

9.  Clinical Bedside Tools to Assess Systemic Sclerosis Vasculopathy: Can Digital Thermal Monitoring and Sublingual Microscopy Identify Patients With Digital Ulcers?

Authors:  Tracy M Frech; Zhining Ou; Angela P Presson
Journal:  J Rheumatol       Date:  2021-02-01       Impact factor: 5.346

10.  MiR-16-5p suppresses myofibroblast activation in systemic sclerosis by inhibiting NOTCH signaling.

Authors:  Qicen Yao; Yixi Xing; Zaiyan Wang; Jin Liang; Qianqi Lin; Meiqiong Huang; Yiling Chen; Bo Lin; Xiayu Xu; Weifei Chen
Journal:  Aging (Albany NY)       Date:  2020-12-19       Impact factor: 5.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.